MARKET

ARCT

ARCT

Arcturus Therape
NASDAQ
13.45
+2.46
+22.38%
After Hours: 13.65 +0.2 +1.49% 19:59 08/21 EDT
OPEN
11.13
PREV CLOSE
10.99
HIGH
13.50
LOW
11.11
VOLUME
2.86M
TURNOVER
--
52 WEEK HIGH
24.17
52 WEEK LOW
5.50
MARKET CAP
382.29M
P/E (TTM)
-4.0582
1D
5D
1M
3M
1Y
5Y
1D
Arcturus Q2 Loss Widens; ARCT-032 Phase 3 Decision Expected In Q4 2026
NASDAQ · 1d ago
Why Moderna's mRNA Cancer Drug Hype Has Gone Too Far
Barron‘s · 1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 1d ago
Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)
TipRanks · 2d ago
Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthrough
Benzinga · 2d ago
Arcturus Therapeutics Earnings Call Balances Progress, Pressure
TipRanks · 2d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 3d ago
Weekly Report: what happened at ARCT last week (0810-0814)?
Weekly Report · 5d ago
More
About ARCT
Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.

Webull offers Arcturus Therapeutics Holdings Inc stock information, including NASDAQ: ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARCT stock methods without spending real money on the virtual paper trading platform.